Description
GDC-0623 is an inhibitor of MEK that prevents MEK-dependent B-Raf and KRAS signaling. GDC-0623 exhibits anticancer chemotherapeutic activity and is currently in clinical trials as a potential treatment for several cancers.
Product Unit Size | Cost | Quantity | Stock |
---|
GDC-0623 is an inhibitor of MEK that prevents MEK-dependent B-Raf and KRAS signaling. GDC-0623 exhibits anticancer chemotherapeutic activity and is currently in clinical trials as a potential treatment for several cancers.
Cas No. | 1168091-68-6 |
---|---|
Purity | ≥98% |
Formula | C16H14FIN4O3 |
Formula Wt. | 456.21 |
IUPAC Name | 5-(2-fluoro-4-iodoanilino)-N-(2-hydroxyethoxy)imidazo[1,5-a]pyridine-6-carboxamide |
Solubility | DMSO 91 mg/mL warmed (199.46 mM) Ethanol 5 mg/mL warmed (10.95 mM) Water Insoluble |
Appearance | Beige Powder |
Store Temp | 4°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet | |
Brochures |
Hatzivassiliou G, Haling JR, Chen H, et al. Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancers. Nature. 2013 Sep 12;501(7466):232-6. PMID: 23934108.
Synthetic steroid; glucocorticoid agonist.
Lincosamide; peptidyl transferase inhibitor, pr...
Corticosteroid; glucocorticoid agonist.
Bipyridamine toxin.
Isoflavone, phytoestrogen found in soy
Potential AhR binding agent.
BH3 mimetic; Bcl-2 and Bcl-xl inhibitor.
GABA-A α5/3/2 positive modulator.
Respiratory toxin, mitochondrial permeability t...
c-Raf inhibitor.
GSK3 inhibitor.
TNKS1/2 inhibitor.
PPARγ coactivator-1α expression stimulator.
Diterpenoid epoxide found in Tripterygium.
PI3K and PDK1 inhibitor.
Diterpene found in brewed, unfiltered coffee; F...
Endogenous peptide involved in vascular contrac...
Endogenous peptide hormone fragment, involved i...
Alkaloid found in Fabaceae family plants; α3β...
Dihydrofolate reductase inhibitor.